Drupal.behaviors.print = function(context) {window.print();window.close();}>
BG Medicine IPO Still a Possibility Despite Price Issue
December 17, 2010
BG Medicine IPO Still a Possibility Despite Price Issue
A BG Medicine official contradicted a news report which claimed the company had withdrawn its IPO.
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
BG Medicine Goes Public, Begins Trading on Nasdaq
February 4, 2011 / GenomeWeb Daily News
BG Medicine Lowers Expected IPO Share Price to $7
February 1, 2011 / GenomeWeb Daily News
BG Medicine Partners with Kindstar to Offer Galectin-3 Testing in China
October 24, 2012 / GenomeWeb Daily News
BG Medicine's Q1 Revenues Fall on Lower Service Revenue
May 15, 2012 / GenomeWeb Daily News
BG Medicine, Boston Scientific Study Galectin-3 for CRT
March 30, 2011 / GenomeWeb Daily News